More Information (API / 500mg x 28 tabs)

Active Ingredients

Deferasirox 500mg

Free-From

Indicators

Deferasirox is indicated in the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adults and paediatric patients 6 years and older. It is also indicated for the treatment of chronic iron overload in paediatric patients aged 2 to 5 years who are unable to take desferrioxamine therapy or in whom desferrioxamine has proven ineffective. Deferasirox is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.

Tablet Description

White to off white, round, flat tablet with beveled edge and debossed with DS on the one side and 500 on other side.

Storage Conditions

Store below 25 degrees Celsius

Additional Information

  • Generic Name: Deferasirox
  • PBS Listed: ✔
  • RPBS: ✘
  • Strength: 500mg
  • Dosage: Tablet, dispersible
  • Pack Size: 28
  • Schedule: S4
  • Shelf Life: 24 Months
  • Innovator: Jadenu

Warnings

See Product Information and Consumer Medicine Information for this product

More Information (CH2 / 500mg x 28 tabs)

Active Ingredients

Deferasirox 500mg

Free-From

Indicators

Deferasirox is indicated in the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adults and paediatric patients 6 years and older. It is also indicated for the treatment of chronic iron overload in paediatric patients aged 2 to 5 years who are unable to take desferrioxamine therapy or in whom desferrioxamine has proven ineffective. Deferasirox is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.

Tablet Description

White to off white, round, flat tablet with beveled edge and debossed with DS on the one side and 500 on other side.

Storage Conditions

Store below 25 degrees Celsius

Additional Information

  • Generic Name: Deferasirox
  • PBS Listed: ✔
  • RPBS: ✘
  • Strength: 500mg
  • Dosage: Tablet, dispersible
  • Pack Size: 28
  • Schedule: S4
  • Shelf Life: 24 Months
  • Innovator: Jadenu

Warnings

See Product Information and Consumer Medicine Information for this product

More Information (Symbion / 500mg x 28 tabs)

Active Ingredients

Deferasirox 500mg

Free-From

Indicators

Deferasirox is indicated in the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adults and paediatric patients 6 years and older. It is also indicated for the treatment of chronic iron overload in paediatric patients aged 2 to 5 years who are unable to take desferrioxamine therapy or in whom desferrioxamine has proven ineffective. Deferasirox is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.

Tablet Description

White to off white, round, flat tablet with beveled edge and debossed with DS on the one side and 500 on other side.

Storage Conditions

Store below 25 degrees Celsius

Additional Information

  • Generic Name: Deferasirox
  • PBS Listed: ✔
  • RPBS: ✘
  • Strength: 500mg
  • Dosage: Tablet, dispersible
  • Pack Size: 28
  • Schedule: S4
  • Shelf Life: 24 Months
  • Innovator: Jadenu

Warnings

See Product Information and Consumer Medicine Information for this product

Connecting Care, Simplifying Supply.

At Pharmacor, we bridge the gap between healthcare providers and seamless supply solutions, ensuring care is always within reach.

Shop All

Maximise Your Benefits Today

icon icon

Subscribe & Save 

Get more for less with competitive volume discounts.

See Offers
icon icon

Loyalty Rewards 

Double Points Promotions

See Offers
icon icon

Bundle Deals

Get more for less with competitive volume discounts.

See Offers
icon icon

Pharmacor Punch Card

Double Points Promotions

See Offers
icon icon

Dose Aid Admin

Double Points Promotions

See Offers